Our website uses cookies to distinguish you from other users of our site. This helps us to continually improve your experience when using our website. We also use external analytics software which may set additional cookies to perform their analysis. These cookies (and any others in use) are detailed in our site Privacy and Cookie Policies. You can delete or disable these cookies in your web browser at any time but doing so may impact website functionality and user experience.

Cambridge Enterprise portfolio company Sphere Fluidics has been named one of the UK's top 50 disruptive SMEs by Real Business.

The award was bestowed during the fourth annual Everline Future 50 competition in which organisers search the UK business landscape for companies that are ‘breaking down barriers, creating innovative products and – most importantly – disrupting previously stagnant industries.’

Sphere Fluidics, which is commercialising lab-on-a-chip and picodroplet technology developed at the University of Cambridge, based on the research of Professors Chris Abell and Wilhelm Huck of the Department of Chemistry, has created unique products for use in single cell analysis and characterisation and also provides collaborative R&D services in this area.

It is great news that Cyto-Mine and our single cell analysis technology has been recognised by the broader UK business community as revolutionary.

 Dr Rob Marchmont

Dr Rob Marchmont, Fluidic’s Commerical Director, attended the awards ceremony and stated “It is great news that Cyto-Mine and our single cell analysis technology has been recognised by the broader UK business community as revolutionary.”

Image: Macro closeup of condensation water bubbles
© 2010 Evan Sharboneau and PhotoExtremist.com Blog | YouTube | Flickr | Twitter | Facebook

Sign up to our newsletter

Stay in touch with the latest updates from Cambridge Enterprise

Sign up now